Quantification of human growth hormone in serum with a labeled protein as an internal standard: essential considerations.

To manage and inform diagnostic or therapeutic decisions, measurement results which are accurate, specific, and comparable between laboratories are required. Two challenges associated with this are the definition of the measurand and the commutability of the reference standard used. Once the measurand is defined, the next step in improving standardization is developing traceable quantification methods for proteins in biological fluids. A novel reference method for the quantification of recombinant human growth hormone (rhGH) in serum has been developed using multistep sample cleanup at the protein level, tryptic digestion, and isotope dilution mass spectrometry (IDMS). Critical considerations for using isotopically labeled rhGH as the internal standard are described. A bulk serum sample was prepared at the clinically relevant level of 10 ng/g and quantified using the method described to give results traceable to the International System of Units (SI) with a total measurement uncertainty of <20%. Results compared favorably with an orthogonal traceable method using total tryptic digestion, peptide separation, and isotope dilution mass spectrometry.

[1]  Gary L. Myers,et al.  Commutability still matters. , 2013, Clinical chemistry.

[2]  Bernhard Kuster,et al.  DMSO enhances electrospray response, boosting sensitivity of proteomic experiments , 2013, Nature Methods.

[3]  A. Ashcroft,et al.  The role of ion mobility spectrometry-mass spectrometry in the analysis of protein reference standards. , 2013, Analytical chemistry.

[4]  C. Sturgeon,et al.  Gaps in the traceability chain of human growth hormone measurements. , 2013, Clinical chemistry.

[5]  J. Kratzsch,et al.  High sensitivity mass spectrometric quantification of serum growth hormone by amphiphilic peptide conjugation. , 2012, Journal of mass spectrometry : JMS.

[6]  J. Garin,et al.  Mass spectrometry‐based absolute protein quantification: PSAQ™ strategy makes use of “noncanonical” proteotypic peptides , 2012, Proteomics.

[7]  M. Quaglia,et al.  Considering the advantages and pitfalls of the use of isotopically labeled protein standards for accurate protein quantification. , 2011, Bioanalysis.

[8]  D. S. Hage,et al.  Immunoaffinity chromatography: an introduction to applications and recent developments. , 2010, Bioanalysis.

[9]  Brendan MacLean,et al.  Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments , 2022 .

[10]  J. Kratzsch,et al.  Troubleshooting PEG-hGH detection supporting pharmacokinetic evaluation in growth hormone deficient patients. , 2010, Journal of pharmacological and toxicological methods.

[11]  N. Anderson,et al.  The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. , 2010, Clinical chemistry.

[12]  M. Bidlingmaier,et al.  Quantification of growth hormone in serum by isotope dilution mass spectrometry. , 2009, Analytical biochemistry.

[13]  M. Quaglia,et al.  Fully traceable absolute protein quantification of somatropin that allows independent comparison of somatropin standards. , 2009, Clinical chemistry.

[14]  G. Baumann Growth hormone isoforms. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[15]  J. Garin,et al.  Isotope dilution strategies for absolute quantitative proteomics. , 2009, Journal of proteomics.

[16]  Mingliang Ye,et al.  Selective on-line serum peptide extraction and multidimensional separation by coupling a restricted-access material-based capillary trap column with nanoliquid chromatography-tandem mass spectrometry. , 2009, Journal of chromatography. A.

[17]  Mathieu Dubois,et al.  Bioanalysis of recombinant proteins and antibodies by mass spectrometry. , 2009, The Analyst.

[18]  G. Nicol,et al.  Use of an Immunoaffinity-Mass Spectrometry-based Approach for the Quantification of Protein Biomarkers from Serum Samples of Lung Cancer Patients* , 2008, Molecular & Cellular Proteomics.

[19]  C. Pritchard,et al.  Amine-reactive isobaric tagging reagents: requirements for absolute quantification of proteins and peptides. , 2008, Analytical biochemistry.

[20]  N. Zolotarjova,et al.  Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum. , 2008, Journal of chromatography. A.

[21]  B. Güttler,et al.  Protein quantification by isotope dilution mass spectrometry of proteolytic fragments: cleavage rate and accuracy. , 2008, Analytical chemistry.

[22]  S. Carr,et al.  Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution*S , 2007, Molecular & Cellular Proteomics.

[23]  F. Vandenesch,et al.  Isotope-labeled Protein Standards , 2007, Molecular & Cellular Proteomics.

[24]  Ronald J. Moore,et al.  Evaluation of Multiprotein Immunoaffinity Subtraction for Plasma Proteomics and Candidate Biomarker Discovery Using Mass Spectrometry*S , 2006, Molecular & Cellular Proteomics.

[25]  W Greg Miller,et al.  Why commutability matters. , 2006, Clinical chemistry.

[26]  N. Cassiano,et al.  Development of restricted-access media supports and their application to the direct analysis of biological fluid samples via high-performance liquid chromatography , 2006, Analytical and bioanalytical chemistry.

[27]  David M Bunk,et al.  Characterization of a new certified reference material for human cardiac troponin I. , 2006, Clinical chemistry.

[28]  W. Barrett,et al.  Differences among techniques for high‐abundant protein depletion , 2005, Proteomics.

[29]  Mark Brönstrup,et al.  Absolute quantification strategies in proteomics based on mass spectrometry , 2004, Expert review of proteomics.

[30]  J. Veuthey,et al.  Restricted access materials and large particle supports for on-line sample preparation: an attractive approach for biological fluids analysis. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[31]  L L Needham,et al.  Isotope dilution--mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. , 1996, Clinical chemistry.

[32]  A. Henrion Reduction of systematic errors in quantitative analysis by isotope dilution mass spectrometry (IDMS): an iterative method , 1994 .